| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 5.8% | +37.5% | $10,678,250 | +$2,780,523 | 3,841,097 | +35.2% | BlackRock, Inc. | 31 Mar 2025 |
| VANGUARD GROUP INC | 5.6% | $11,744,252 | 3,728,334 | The Vanguard Group | 30 Jun 2025 | |||
| PFIZER INC | 3.6% | $6,704,178 | 2,411,575 | Pfizer Inc. 13-5315170 | 31 Dec 2024 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 25,150,264 | $51,811,088 | -$9,699,936 | $2.06 | 109 |
| 2025 Q2 | 28,660,334 | $90,269,224 | -$11,262,615 | $3.15 | 114 |
| 2025 Q1 | 32,345,011 | $101,559,895 | +$10,196,300 | $3.14 | 116 |
| 2024 Q4 | 28,092,578 | $121,918,732 | +$50,159,924 | $4.34 | 117 |
| 2024 Q3 | 12,761,449 | $34,074,638 | -$895,795 | $2.67 | 82 |
| 2024 Q2 | 13,089,737 | $29,054,064 | +$5,567,075 | $2.22 | 90 |
| 2024 Q1 | 8,576,486 | $45,797,587 | +$17,940,647 | $5.34 | 74 |
| 2023 Q4 | 5,309,425 | $7,858,363 | -$215,046 | $1.48 | 55 |
| 2023 Q3 | 5,456,265 | $7,583,910 | -$756,925 | $1.39 | 55 |
| 2023 Q2 | 5,991,988 | $8,808,700 | -$1,673,969 | $1.47 | 50 |
| 2023 Q1 | 7,049,719 | $11,633,255 | -$748,502 | $1.65 | 52 |
| 2022 Q4 | 7,699,341 | $10,776,288 | -$189,952 | $1.4 | 55 |
| 2022 Q3 | 7,924,242 | $12,205,032 | -$1,956,121 | $1.54 | 47 |
| 2022 Q2 | 8,925,020 | $19,636,792 | -$17,827,128 | $2.2 | 54 |
| 2022 Q1 | 16,524,301 | $40,953,207 | -$30,166,620 | $2.48 | 81 |
| 2021 Q4 | 22,015,576 | $132,083,136 | +$5,192,808 | $6.01 | 81 |
| 2021 Q3 | 21,121,086 | $140,722,888 | -$35,953,961 | $6.66 | 82 |
| 2021 Q2 | 26,525,986 | $176,397,333 | +$10,825,969 | $6.65 | 81 |
| 2021 Q1 | 24,079,194 | $222,960,463 | -$69,848,932 | $9.26 | 70 |
| 2020 Q4 | 26,636,620 | $479,141,900 | +$144,188,615 | $17.99 | 79 |
| 2020 Q3 | 18,710,542 | $265,500,071 | +$207,902,213 | $14.19 | 63 |
| 2020 Q2 | 4,923,525 | $24,668,025 | +$24,668,026 | $5.01 | 23 |